Status:

ACTIVE_NOT_RECRUITING

Circulating RNAs in Acute Congestive Heart Failure

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

Conditions:

Acute Congestive Heart Failure

Heart Failure With Reduced Ejection Fraction

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this American Heart Association-funded and NIH-funded study is to examine circulating RNAs in the acute CHF setting, how they change with decongestive therapy, and their function in vit...

Detailed Description

Nearly 5 million people in the United States have congestive heart failure (CHF). Although medical therapy such as beta-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin-receptor b...

Eligibility Criteria

Inclusion

  • Age \>/= 18 years of age
  • Assessment of LV function within the last year or planned during hospital admission
  • Acute CHF diagnosis, requiring clinical signs and/or symptoms (including exertional or rest dyspnea, orthopnea or PND) AND
  • N-terminal pro-BNP level \> 1000 pg/ml or BNP \> 400 pg/ml, OR
  • Clinical evidence of congestion:
  • X-ray evidence of pulmonary edema or pleural effusions
  • Elevated JVP, lower extremity edema, or rales on pulmonary examination
  • Right heart catheterization evidence of elevated filling pressures (RA pressure \> 10 mmHg; PCWP \> 18 mmHg)
  • Clinical response to IV diuretic therapy (as judged by a physician)

Exclusion

  • Hematocrit at time of consent \< 30%
  • End-stage non-cardiovascular diseases
  • Known HIV/AIDS
  • Cirrhosis
  • Hemodialysis-dependent renal failure
  • Pregnancy (as adjudicated by patient history)
  • Ventricular assist device support
  • Acute mechanical support on admission
  • Post-heart transplant
  • Malignancy within the last 1 year or clinically active rheumatologic or autoimmune illnesses

Key Trial Info

Start Date :

August 17 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03345446

Start Date

August 17 2016

End Date

December 31 2026

Last Update

October 23 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

3

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215